Laura Silva
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Neuroprotective effects of VCE-004.8 in a rat model of neonatal stroke.
Journal: European journal of pharmacology
Published: December 11, 2023
Cannabidiol reduces intraventricular hemorrhage brain damage, preserving myelination and preventing blood brain barrier dysfunction in immature rats.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: September 07, 2023
Protein Carbonylation as a Biomarker of Oxidative Stress and a Therapeutic Target in Neonatal Brain Damage.
Journal: Antioxidants (Basel, Switzerland)
Published: August 22, 2023
Effects of cannabidiol in post-stroke mood disorders in neonatal rats.
Journal: Pediatric research
Published: July 10, 2023
The Role of the Dopamine System in Post-Stroke Mood Disorders in Newborn Rats.
Journal: International journal of molecular sciences
Published: January 11, 2023
Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived Neurons.
Journal: International journal of molecular sciences
Published: July 22, 2022
Role of 5HT1A Receptors in the Neuroprotective and Behavioral Effects of Cannabidiol in Hypoxic-Ischemic Newborn Piglets.
Journal: Frontiers in pharmacology
Published: April 21, 2022
Neuroprotective Efficacy of Betulinic Acid Hydroxamate, a B55α/PP2A Activator, in Acute Hypoxia-Ischemia-Induced Brain Damage in Newborn Rats.
Journal: Translational stroke research
Published: October 01, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026